Finland· FI-REL-REL1971

Becenun

A carmustine product containing carmustine, registered in Finland by Bristol-Myers Squibb Ab. The same ATC class is registered in 16 of our 19 countries.

ATC L01AD01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedBecenunATCL01AD01REGISTER NO.FI-REL-REL1971PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Carmustine is registered in 16 of 19 countries.

Countries holding a registration under ATC L01AD01 (carmustine), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 9 of them publish a price we can compare per daily dose

Carmustine · ATC L01AD01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Carmustine
Manufacturer
Bristol-Myers Squibb Ab
Country
Finland (FI)
ATC code
L01AD01
ATC class
Carmustine
Defined daily dose
8.57 mg, P
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

253 interactions on record for carmustine.

Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Carmustine · interactions on record

253 records

  • 36 severe
  • 108 moderate
  • 15 minor
  • 94 info

Most severe, free to view

  • CimetidineA02BA01severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • Nalidixic acidJ01MB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Carmustine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All carmustine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Carmubris®, Carmustin Accord
  • Belgium · Carmustine Tillomed
  • Cyprus · Carmustine Accord, Carmustine Msn
  • Czechia · Carmustine Accord, Carmustine Msn
  • Germany · Carmubris, Carmustin Accord
  • Denmark · Carmustin Waymade, Carmustine Accord
  • Estonia · Carmustine Accord
  • Spain · Bicnu, Carmustina Accord
  • France · Bicnu, Carmustine Accord
  • United Kingdom (Northern Ireland) · Carmustine Accord, Carmustine Accord Healthcare
  • Greece · Carmustine Tillomed, Carmustine Waymade
  • Croatia · Karmustin Msn, Karmustin Pliva
  • Hungary · Carmustine Teva, Carmustine Tillomed
  • Ireland · Carmustine Accord, Carmustine Accord Healthcare Ireland
  • Iceland · Carmustine Medac, Carmustine Stada
  • Italy · Bicnu, Carmustina Hikma
  • Liechtenstein · Carmustin Medac
  • Lithuania · Carmustine Zentiva
  • Malta · Carmustine Dr. Reddys
  • Netherlands · Carmustine Accord, Carmustine Glenmark
  • Norway · Carmustine, Carmustine Accord
  • Poland · Carmustine Accord, Carmustine Accordpharma
  • Portugal · Carmustina Accord, Carmustina Accordpharma
  • Romania · Carmustină Waymade
  • Sweden · Carmustine, Carmustine Accord
  • Slovenia · Karmustin Teva, Karmustin Tillomed Pharma
  • Slovakia · Carmustine Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1558c87a-bb13-4eec-99b0-f6d02a296ca5
GET /v1/drugs/1558c87a-bb13-4eec-99b0-f6d02a296ca5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "infuusiokuiva-aine",
  "route": null,
  "ddd_unit": null,
  "strength": "100 mg",
  "atc_label": "karmustiini",
  "ma_number": "9241",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL1971",
  "authorised_at": "1986-02-26"
}

See everything about carmustine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.